Even if genes affect intelligence, we can’t engineer cleverness
By Jim Kozubek,
Aeon
| 12. 11. 2017
First, let me tell you how smart I am. So smart. My fifth-grade teacher said I was gifted in mathematics and, looking back, I have to admit that she was right. I’ve properly grasped the character of metaphysics as trope nominalism, and I can tell you that time exists, but that it can’t be integrated into a fundamental equation. I’m also street-smart. Most of the things that other people say are only partially true. And I can tell.
A paper published in Nature Genetics in 2017 reported that, after analysing tens of thousands of genomes, scientists had tied 52 genes to human intelligence, though no single variant contributed more than a tiny fraction of a single percentage point to intelligence. As the senior author of the study Danielle Posthuma, a statistical geneticist at the Vrije Universiteit (VU) Amsterdam and VU University Medical Center Amsterdam, told The New York Times, ‘there’s a long way to go’ before scientists can actually predict intelligence using genetics. Even so, it is easy to imagine social impacts that are unsettling: students stapling their...
Related Articles
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...